Go Deep
Utah Medical Products, Inc.
Utah Medical Products, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 20,433 | 22.8 | 1.94 | 0.00 | 7,114.91 |
| Oct 2026 | 20,427 | 22.8 | 1.95 | 0.00 | 7,101.12 |
| Oct 2026 | 20,417 | 22.8 | 1.95 | 0.00 | 7,114.48 |
| Oct 2026 | 20,449 | 22.7 | 1.94 | 0.00 | 7,057.21 |
| Oct 2026 | 20,446 | 22.7 | 1.94 | 0.00 | 7,068.56 |
| Oct 2026 | 20,405 | 22.9 | 1.95 | 0.00 | 7,117.87 |
| Oct 2026 | 20,432 | 22.8 | 1.94 | 0.00 | 7,067.18 |
| Oct 2026 | 20,406 | 22.9 | 1.95 | 0.00 | 7,084.98 |
Utah Medical Products, Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 8,529,000.0 | 8,722,000.0 | 9,045,000.0 | 9,812,000.0 |
| Net Profit | 2,686,000.0 | 2,604,000.0 | 2,566,000.0 | 2,631,000.0 |
| EPS | 0.8 | 0.8 | 0.8 | 0.8 |
Utah Medical Products, Inc. Revenue & Profit: Last 4 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Revenue | 38,520,000.0 | 40,903,000.0 | 50,224,000.0 | 52,281,000.0 |
| Net Profit | 11,286,000.0 | 13,874,000.0 | 16,635,000.0 | 16,473,000.0 |
| EPS | 3.5 | 4.2 | 4.6 | 5.7 |
Utah Medical Products, Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 122,542,000.0 | 122,538,000.0 | 135,458,000.0 | 123,874,000.0 | — |
| Total Liabilities | 3,274,000.0 | 5,111,000.0 | 7,145,000.0 | 9,620,000.0 | — |
| Total Equity | 119,268,000.0 | 117,427,000.0 | 128,313,000.0 | 114,254,000.0 | — |
Owes vs Owns
Utah Medical Products, Inc. owed $0.02 for every $1 it owned in Jun 2026, down from $0.08 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.02× | 0.03× | 0.04× | 0.05× | 0.08× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Utah Medical Products, Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 70.0%Receivables 2.9%Inventory 6.5%Fixed assets (tangible) 8.1%Intangible assets 12.2%
How it's funded — Dec 2025
Payables 0.7%Other liabilities 1.7%Shareholders' equity 97.3%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 85.8 | 83.0 | 92.9 | 75.1 |
| Receivables | 3.5 | 4.1 | 3.4 | 5.5 |
| Inventory | 7.9 | 8.8 | 9.6 | 8.8 |
| Fixed assets (tangible) | 9.9 | 9.8 | 10.6 | 10.2 |
| Intangible assets | 14.9 | 16.4 | 18.6 | 23.7 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 0.5 | 0.4 | 0.4 | 0.5 |
| Liabilities & equity | ||||
| Short-term debt | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term debt | 0.2 | 0.3 | 0.3 | 0.3 |
| Payables | 0.9 | 0.7 | 0.8 | 1.2 |
| Other liabilities | 2.1 | 4.1 | 6.1 | 8.1 |
| Shareholders' equity | 119.3 | 117.4 | 128.3 | 114.3 |
| Net tangible assets | 104.4 | 101.0 | 109.7 | 90.5 |
Utah Medical Products, Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | 14,692,000.0 | 14,831,000.0 | 22,281,000.0 | 21,147,000.0 | — |
| Investing Activities | -371,000.0 | -208,000.0 | -639,000.0 | -818,000.0 | — |
| Financing Activities | -12,338,000.0 | -23,838,000.0 | -4,165,000.0 | -5,484,000.0 | — |